Patents by Inventor Gerald Villeneuve
Gerald Villeneuve has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 8557765Abstract: Novel spatially-defined macrocyclic compounds incorporating peptide bond surrogates are disclosed. Libraries of these macrocycles are then used to select one or more macrocycle species that exhibit a specific interaction with a particular biological target. In particular, compounds according to the invention are disclosed as agonists or antagonists of a mammalian motilin receptor and a mammalian ghrelin receptor.Type: GrantFiled: May 26, 2009Date of Patent: October 15, 2013Assignee: Tranzyme Pharma Inc.Inventors: Pierre Deslongchamps, Yves Dory, Luc Ouellet, Gérald Villeneuve, Mahesh Ramaseshan, Daniel Fortin, Mark L. Peterson, Hamid R. Hoveyda, Sylvie Beaubien, Éric Marsault, Graeme L. Fraser
-
Patent number: 8022252Abstract: Novel spatially-defined macrocyclic compounds containing specific conformational control elements are disclosed. Libraries of these macrocycles are then used to select one or more macrocycle species that exhibit a specific interaction with a particular biological target. In particular, compounds according to the invention are disclosed as agonists or antagonists of a mammalian motilin receptor and a mammalian ghrelin receptor.Type: GrantFiled: August 25, 2008Date of Patent: September 20, 2011Assignee: Tranzyme Pharma Inc.Inventors: Pierre Deslongchamps, Yves Dory, Kamel Benakli, Éric Marsault, Luc Ouellet, Mahesh Ramaseshan, Martin Vezina, Daniel Fortin, Ruoxi Lan, Shigui Li, Gérald Villeneuve, Hamid R. Hoveyda, Sylvie Beaubien, Mark L. Peterson
-
Patent number: 7772260Abstract: This invention relates to compounds of Formula I and the use of compounds of Formula I as neuroprotective agents in the treatment of neuronal disorders of the central and peripheral nervous systems.Type: GrantFiled: April 6, 2006Date of Patent: August 10, 2010Assignee: Aegera Therapeutics Inc.Inventors: James B. Jaquith, Gerald Villeneuve, Alain Boudreault, Stephen J. Morris, Jon Durkin, John W. Gillard, Kimberley E. Hewitt, H. Nicholas Marsh
-
Patent number: 7741349Abstract: This invention relates to compounds of Formula I and the use of compounds of Formula I as neuroprotective agents in the treatment of neuronal disorders of the central and peripheral nervous systems.Type: GrantFiled: April 5, 2006Date of Patent: June 22, 2010Assignee: Aegera Therapeutics Inc.Inventors: James B. Jaquith, Gerald Villeneuve, Alain Boudreault, Stephen J. Morris, Jon Durkin, John W. Gillard, Kimberley Hewitt, H. Nicholas Marsh
-
Publication number: 20090312540Abstract: Novel spatially-defined macrocyclic compounds incorporating peptide bond surrogates are disclosed. Libraries of these macrocycles are then used to select one or more macrocycle species that exhibit a specific interaction with a particular biological target, in particular, compounds according to the invention are disclosed as agonists or antagonists of a mammalian motilin receptor and a mammalian ghrelin receptor.Type: ApplicationFiled: May 26, 2009Publication date: December 17, 2009Inventors: Pierre Deslongchamps, Yves Dory, Luc Ouellet, Gerald Villeneuve, Mahesh Ramaseshan, Daniel Fortin, Mark L. Peterson, Hamid R. Hoveyda, Sylvie Beaubien, Eric Marsault, Graeme L. Fraser
-
Patent number: 7550431Abstract: Novel spatially-defined macrocyclic compounds incorporating peptide bond surrogates are disclosed. Libraries of these macrocycles are then used to select one or more macrocycle species that exhibit a specific interaction with a particular biological target. In particular, compounds according to the invention are disclosed as agonists or antagonists of a mammalian motilin receptor and a mammalian ghrelin receptor.Type: GrantFiled: August 2, 2004Date of Patent: June 23, 2009Assignee: Tranzyme Pharma Inc.Inventors: Pierre Deslongchamps, Yves Dory, Luc Ouellet, Gérald Villeneuve, Mahesh Ramaseshan, Daniel Fortin, Mark L. Peterson, Hamid R. Hoveyda, Sylvie Beaubien, Éric Marsault, Graeme L. Fraser
-
Publication number: 20090137817Abstract: Novel spatially-defined macrocyclic compounds containing specific conformational control elements are disclosed. Libraries of these macrocycles are then used to select one or more macrocycle species that exhibit a specific interaction with a particular biological target. In particular, compounds according to the invention are disclosed as agonists or antagonists of a mammalian motilin receptor and a mammalian ghrelin receptor.Type: ApplicationFiled: August 25, 2008Publication date: May 28, 2009Inventors: Pierre Deslongchamps, Yves Dory, Kamel Benakli, Eric Marsault, Luc Ouellet, Mahesh Ramaseshan, Martin Vezina, Daniel Fortin, Ruoxi Lan, Shigui Li, Gerald Villeneuve, Hamid R. Hoveyda, Sylvie Beaubien, Mark L. Peterson
-
Publication number: 20090042953Abstract: This invention relates to compounds of Formula I and the use of compounds of Formula I as neuroprotective agents in the treatment of neuronal disorders of the central and peripheral nervous systems.Type: ApplicationFiled: April 7, 2008Publication date: February 12, 2009Applicant: AEGERA THERAPEUTICS, INC.Inventors: James B. JAQUITH, Gerald VILLENEUVE, Alain BOUDREAULT, Stephen J. MORRIS, Jon DURKIN, John W. GILLARD, Kimberley E. HEWITT, H. Nicholas MARSH
-
Patent number: 7452862Abstract: Novel spatially-defined macrocyclic compounds containing specific conformational control elements are disclosed. Libraries of these macrocycles are then used to select one or more macrocycle species that exhibit a specific interaction with a particular biological target. In particular, compounds according to the invention are disclosed as agonists or antagonists of a mammalian motilin receptor and a mammalian ghrelin receptor.Type: GrantFiled: August 2, 2004Date of Patent: November 18, 2008Assignee: Tranzyme Pharma, Inc.Inventors: Pierre Deslongchamps, Yves Dory, Mark Peterson, Kamel Benakli, Eric Marsault, Luc Ouellet, Mahesh Ramaseshan, Martin Vézina, Daniel Fortin, Ruoxi Lan, Shigui Li, Gérald Villeneuve, Hamid Hoveyda, Sylvie Beaubien, Graeme L Fraser
-
Patent number: 7230019Abstract: This invention relates to compounds of Formula (I) and the use of compounds of Formula (I) as neuroprotective agents in the treatment of neuronal disorders of the central and peripheral nervous systems.Type: GrantFiled: December 16, 2002Date of Patent: June 12, 2007Assignee: Aegera Therapeutics, Inc.Inventors: James B. Jaquith, Gerald Villeneuve, Alain Boudreault, Stephen Morris, Jon Durkin, John W. Gillard, Kimberly Hewitt, H. Nicholas Marsh
-
Publication number: 20070088059Abstract: This invention relates to compounds of Formula I and the use of compounds of Formula I as neuroprotective agents in the treatment of neuronal disorders of the central and peripheral nervous systems.Type: ApplicationFiled: April 6, 2006Publication date: April 19, 2007Inventors: James Jaquith, Gerald Villeneuve, Alain Boudreault, Stephen Morris, Jon Durkin, John Gillard, Kimberley Hewitt, H. Marsh
-
Publication number: 20070021416Abstract: This invention relates to compounds of Formula I and the use of compounds of Formula I as neuroprotective agents in the treatment of neuronal disorders of the central and peripheral nervous systems.Type: ApplicationFiled: April 6, 2006Publication date: January 25, 2007Inventors: James Jaquith, Gerald Villeneuve, Alain Boudreault, Stephen Morris, Jon Durkin, John Gillard, Kimberley Hewitt, H. Marsh
-
Publication number: 20070021476Abstract: This invention relates to compounds of Formula I and the use of compounds of Formula I as neuroprotective agents in the treatment of neuronal disorders of the central and peripheral nervous systems.Type: ApplicationFiled: April 5, 2006Publication date: January 25, 2007Inventors: James Jaquith, Gerald Villeneuve, Alain Boudreault, Stephen Morris, Jon Durkin, John Gillard, Kimberley Hewitt, H. Marsh
-
Patent number: 7137175Abstract: A clipboard comprising a pair of clamping members arranged substantially parallel one above the other and connected to each other via an intermediate connecting member having a spring loaded hinge connection at each of its elongated ends for securely clamping articles, such as paper sheets, between one of the two clamping members and a board. The lower clamping member is used to hold an existing bundle of paper sheets on the board while disengaging the upper clamping member to add extra paper sheets to said existing bundle of paper sheets. The clamping members are positioned substantially parallel to each other and the lower clamping member extends through a slot formed at the center of a back portion of the first clamping member.Type: GrantFiled: October 12, 2001Date of Patent: November 21, 2006Inventor: Gerald Villeneuve
-
Publication number: 20050137127Abstract: Novel spatially-defined macrocyclic compounds containing specific conformational control elements are disclosed. Libraries of these macrocycles are then used to select one or more macrocycle species that exhibit a specific interaction with a particular biological target. In particular, compounds according to the invention are disclosed as agonists or antagonists of a mammalian motilin receptor and a mammalian ghrelin receptor.Type: ApplicationFiled: August 2, 2004Publication date: June 23, 2005Applicant: TRANZYME PHARMA INCInventors: Pierre Deslongchamps, Yves Dory, Mark Peterson, Kamel Benakli, Eric Marsault, Luc Ouellet, Mahesh Ramaseshan, Martin Vezina, Daniel Fortin, Ruoxi Lan, Shigui Li, Gerald Villeneuve, Hamid Hoveyda, Sylvie Beaubien
-
Publication number: 20050119169Abstract: Novel spatially-defined macrocyclic compounds incorporating peptide bond surrogates are disclosed. Libraries of these macrocycles are then used to select one or more macrocycle species that exhibit a specific interaction with a particular biological target. In particular, compounds according to the invention are disclosed as agonists or antagonists of a mammalian motilin receptor and a mammalian ghrelin receptor.Type: ApplicationFiled: August 2, 2004Publication date: June 2, 2005Applicant: TRANZYME PHARMA INC.Inventors: Pierre Deslongchamps, Yves Dory, Luc Ouellet, Gerald Villeneuve, Mahesh Ramaseshan, Daniel Fortin, Mark Peterson, Hamid Hoveyda, Sylvie Beaubien, Eric Marsault
-
Publication number: 20050069492Abstract: This invention relates to compounds of Formula (I) and the use of compounds of Formula (I) as neuroprotective agents in the treatment of neuronal disorders of the central and peripheral nervous systems.Type: ApplicationFiled: December 16, 2002Publication date: March 31, 2005Inventors: James Jaquith, Gerald Villeneuve, Alain Boudreault, Stephen Morris, Jon Durkin, John Gillard, Kimberly Hewitt, H. Marsh
-
Publication number: 20030070264Abstract: A clipboard comprising a pair of clamping members arranged substantially parallel one above the other and connected to each other via an intermediate connecting member having a spring loaded hinge connection at each of its elongated ends for securely clamping articles, such as paper sheets, between one of the two clamping members and a board. The lower clamping member is used to hold an existing bundle of paper sheets on the board while disengaging the upper clamping member to add extra paper sheets to said existing bundle of paper sheets. The clamping members are positioned substantially parallel to each other and the lower clamping member extends through a slot formed at the center of a back portion of the first clamping member.Type: ApplicationFiled: October 12, 2001Publication date: April 17, 2003Inventor: Gerald Villeneuve
-
Patent number: 5758390Abstract: A cable tie which can be used for bundling electrical wires or many other objects. The cable tie of this invention comprises an elongate strap of plastic material composed of a longitudinal channel on one side and transversal notches on the other. This cable tie secures the wires by inserting its tail through either side of its block head. When the tail of the cable tie is inserted into the aperture located on a first side of the block head, the said cable tie becomes locked and impossible to be open (not re-usable). However, when the tail of the cable tie is inserted into the aperture located on the opposite side of the block head, the said cable tie becomes locked but re-usable by using a lever arm mechanism to release the elongate strap from the block head and open the cable tie.Type: GrantFiled: January 21, 1997Date of Patent: June 2, 1998Inventor: Gerald Villeneuve